For nearly 20 years, Integral Molecular has been developing disease-fighting antibodies and fueling the discovery of new treatments for incurable illnesses.
At its Navy Yard facility, Adaptimmune is working to develop the next generation of T-cell treatments for solid tumor cancers.
A new nationwide study led by Penn Medicine aims to identify the cause of common transplant surgery complications to improve transplant survival rates.
From new investment models for biotech to ice cream as medicine, the new citywide innovation fest explored what’s next for the city’s science sector.
Philly’s Beyond/Hello dispensary is on a mission to destigmatize medical marijuana in Pennsylvania.
The Caspar Wistar Fellows program will help aspiring scientists pursue new research in cancer biology, immunology, virology and genetics.
With the combined expertise of leading gene and cell therapy researchers, Tmunity is developing the next wave of immunotherapies for cancer and other diseases.
A new documentary by former Philadelphia news anchor Renee Chenault-Fattah takes a closer look at what can be done to reverse the trend.
The first-of-its-kind study wants to determine whether CBD can relieve symptoms of arthritis in dogs.
UE LifeSciences developed the iBreastExam, a handheld, battery-operated device, that provides easy access to breast cancer screening.
In light of the recent news, Penn oncologist Susan Domcheck debunks a few myths about men and breast cancer.
Villanova University professor Dr. Qianhong Wu has invented a “Smart Brain” that simulates exactly what happens in the brain during head injuries.
By treating canines as patients, the One Health Company wants to cure cancer in dogs and eventually in people.
Advocates with Philly nonprofit Maternity Care Coalition hit the road to visit pregnant women and new moms at home and in prison.
The refurbished facility features next-generation technologies designed to streamline R&D and the manufacturing of new medicines.